Literature DB >> 8487654

Effect of heparin on insulin-glucose interactions measured by the minimal model technique: implications for reproducibility using this method.

S L Abbate1, W Y Fujimoto, J D Brunzell, S E Kahn.   

Abstract

The minimal model technique permits investigation of glucose and insulin interactions during a frequently sampled intravenous glucose tolerance test (FSIGT). The model allows measurement of several important variables including insulin sensitivity (SI), glucose effectiveness at basal insulin (SG), and glucose effectiveness at zero insulin (GEZI). In addition, from the FSIGT, first-phase insulin secretion (AIRglucose) and the glucose disappearance constant (Kg) can be estimated. The estimates obtained using the minimal model technique could be of importance in understanding potential relationships between carbohydrate and lipid metabolism. In studying lipoprotein lipase (LPL) activity and mass as one of the elements of lipid metabolism, heparin administration is necessary. However, the effect of administration of this agent on factors important in carbohydrate metabolism has not been fully elucidated. Therefore, to assess the effect of heparin on insulin-glucose interactions, we performed paired studies in which subjects randomly underwent FSIGT studies 20 minutes following bolus injections of heparin or saline. None of the measured parameters was influenced by heparin administration just before the FSIGT. Since these estimates were not affected by heparin administration, these studies also permitted assessment of the coefficient of variation of replicate analysis for all values generated using the minimal model technique. The coefficients of variation of replicate analysis calculated from these two studies were 16.9% for SI, 16.6% for SG, 18.3% for GEZI, 20.6% for AIRglucose, and 14.5% for Kg. These results suggest that heparin can be administered as part of a procedure that would allow concurrent assessment of various aspects of both carbohydrate and lipid metabolism.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8487654     DOI: 10.1016/0026-0495(93)90086-4

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Plasma sterol evidence for decreased absorption and increased synthesis of cholesterol in insulin resistance and obesity.

Authors:  Pathmaja Paramsothy; Robert H Knopp; Steven E Kahn; Barbara M Retzlaff; Brian Fish; Lina Ma; Richard E Ostlund
Journal:  Am J Clin Nutr       Date:  2011-09-21       Impact factor: 7.045

2.  Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

Authors:  M Cnop; P J Havel; K M Utzschneider; D B Carr; M K Sinha; E J Boyko; B M Retzlaff; R H Knopp; J D Brunzell; S E Kahn
Journal:  Diabetologia       Date:  2003-04-10       Impact factor: 10.122

3.  The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans.

Authors:  R L Prigeon; M E Røder; D Porte; S E Kahn
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

4.  Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies.

Authors:  K M Utzschneider; R L Prigeon; J Tong; F Gerchman; D B Carr; S Zraika; J Udayasankar; B Montgomery; A Mari; S E Kahn
Journal:  Diabetologia       Date:  2007-10-11       Impact factor: 10.122

5.  Small changes in glucose variability induced by low and high glycemic index diets are not associated with changes in β-cell function in adults with pre-diabetes.

Authors:  Kristina M Utzschneider; Tonya N Johnson; Kara L Breymeyer; Lisa Bettcher; Daniel Raftery; Katherine M Newton; Marian L Neuhouser
Journal:  J Diabetes Complications       Date:  2020-04-18       Impact factor: 2.852

Review 6.  The β Cell in Diabetes: Integrating Biomarkers With Functional Measures.

Authors:  Steven E Kahn; Yi-Chun Chen; Nathalie Esser; Austin J Taylor; Daniël H van Raalte; Sakeneh Zraika; C Bruce Verchere
Journal:  Endocr Rev       Date:  2021-09-28       Impact factor: 25.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.